GLF
KZR

Groupe la Francaise’s Kezar Life Sciences KZR Stock Holding History

Groupe la Francaise’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$597K Buy
+80,400
New +$523K 0.01% 291

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Groupe la Francaise's KZR Position: Q1 2026 in Review

Groupe la Francaise opened a new position in Kezar Life Sciences (KZR) in Q1 2026: 80,400 shares worth $597K. The stake represents 0.01% of the portfolio and ranks #291 among its holdings.

43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Groupe la Francaise held 80,400 shares of Kezar Life Sciences worth $597K as of Q1 2026.
  • Kezar Life Sciences was a new Groupe la Francaise position in Q1 2026.
  • Kezar Life Sciences made up 0.01% of Groupe la Francaise's portfolio in Q1 2026, its #291 holding.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.